Loading stock data…
Loading stock data…
US$15.50
Get one email when ENDI crosses your level. Checked every 15 minutes during market hours.
▲ +0.15 (0.98%)up today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
59.7
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.05
Bullish momentumMACD above its signal line (-0.07).
50-day average
15.43
Price aboveShort-term trend reference.
200-day average
16.24
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Financial Services · Asset Management
Endi Corp is a cutting-edge biotechnology company focused on developing innovative therapeutic solutions to address complex medical conditions. The primary function of Endi Corp is to leverage advanced biotechnological research to create groundbreaking treatments that can significantly impact healthcare outcomes. The company's pipeline includes a diverse range of potential therapies aimed at conditions such as autoimmune diseases, genetic disorders, and oncology. By engaging in strategic partner…
www.crossingbridge.com| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-03-18 | 2.51 | 2.69 | ✓ Beat |
| 2026-01-23 | 1.61 | 1.87 | ✓ Beat |
| 2025-12-04 | 0.92 | 0.94 | ✓ Beat |
Companies in the same industry, via Finnhub